DrugsNews.net

Drugs Xagena

Xagena Mappa
Medical Meeting
XagenaNewsletter
Cardiobase

Search results for "Provenge"

Provenge ( Sipuleucel-T ) is an autologous cellular immunotherapy designed to stimulate a patient’s own immune system against cancer. Provenge is manufactured in several steps. First the patient’s bl ...


The European Medicines Agency’s Committee for Medicinal Products for Human Use ( CHMP ) has recommended granting a marketing authorisation for a new advanced-therapy medicinal product ( ATMP ). Proven ...


Dendreon has announced that the European Commission ( EC ) has granted marketing authorization for Provenge ( autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or Sipuleucel-T ) ...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Provenge.The indication rec ...